Case File
efta-01981188DOJ Data Set 10OtherEFTA01981188
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01981188
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Paul S Barre
From:
Jeffrey Epstein
Sent
Wed 10/13/2010 1:41:08 PM
Subject Re: Update and ideas
ok to both
On Wed, Oct 13, 2010 at 3:38 PM, Paul S Barrett
Morning Jeffrey
A few things:
wrote:
- macro trading environment remains tough with all the central bank intervention and quant casing
programs distorting the markets
-I think the opportunities will in specific themes or single name ideas
41
- Buy AMR Converts 6.25% 2014 (Spot = $6.42; Conversion Px = $9.90)
- we should buy 2MM of this
JPM analyst raised Dec-II price target to $13.50 from $12.50 a few weeks ago, implying 115%
upside. This compares to average coverage upside of 45% (8 names covered).
Historically, buying airlines in September-October and holding until April or May yielded positive
returns 90% of the time.
AMR is highly leveraged yet the analyst believes deleveraging and balance sheet repair will be main
industry themes over next year
#2
- buy ARS denominated Argentine GDP Warrants (these are warrants issued by the
government with the payout linked to nominal GDP growth)
- Px target ARS22.09 ($5.59); current ARS 12.64 ($3.20)
- would do $10MM notional which costs $320,000
Will call you shortly to discuss
EFTA_R1_00469664
EFTA01981188
Paul
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
This email is confidential and subject to important disclaimers and conditions including on
offers for the purchase or sale of securities, accuracy and completeness of information,
viruses, confidentiality, legal privilege, and legal entity disclaimers, available at
http://www.jpmorgan.com/pages/disclosures/email.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation@gmail.com, and
destroy this communication and all copies thereof,
including all attachments.
EFTA_R1_00469665
EFTA01981189
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
jeevacation@gmail.comURL
http://www.jpmorgan.com/pages/disclosures/emailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.